: Patients in clinical trials were generally younger, with a mean age of 58 compared to 61 in this real-world group.
Provide a breakdown of the used by the researchers in this study. Which of these would be most helpful for you?
: For those who stopped the medication, the median time until they did so was only 7 months .
The search for a "616 KB" article points directly to a significant medical study titled
Toxicities and outcomes of 616 ibrutinib-treated patients in ... - PMC
: Despite the high rate of stopping, the overall survival and progression-free survival (estimated at 35 months) remained excellent. Real-World vs. Clinical Trials
: Patients in clinical trials were generally younger, with a mean age of 58 compared to 61 in this real-world group.
Provide a breakdown of the used by the researchers in this study. Which of these would be most helpful for you? (616 KB)
: For those who stopped the medication, the median time until they did so was only 7 months . : Patients in clinical trials were generally younger,
The search for a "616 KB" article points directly to a significant medical study titled (616 KB)
Toxicities and outcomes of 616 ibrutinib-treated patients in ... - PMC
: Despite the high rate of stopping, the overall survival and progression-free survival (estimated at 35 months) remained excellent. Real-World vs. Clinical Trials